Review
Open access
Aug 2026
Beyond LDL-C: Modern Lipid Management for ASCVD Prevention in Primary Care
Treatment paradigms emphasize early intensification of therapy and addition of non-statin agents, and polygenic risk scoring and RNA-based therapies may offer opportunities to identify and treat those at highest residual risk.
Andrew Carlson, Zaid A. Zayyad, Stefanie Driesenga et al.
· Cardiology and Therapy · 0 citations